Literature DB >> 4670494

Susceptibility of mycobacteria to rifampin.

C L Woodley, J O Kilburn, H L David, V A Silcox.   

Abstract

The Mycobacterium species M. tuberculosis, M. avium-intracellulare, M. kansasii, M. marinum, M. scrofulaceum, M. fortuitum, M. terrae, and M. gordonae were analyzed for their susceptibility to rifampin. M. tuberculosis, M. kansasii, and M. marinum were susceptible to the antibiotic, and resistant populations developed as a result of the interplay of mutation and selection. The mutation rates (susceptibility --> resistance) were calculated to be 4.9 x 10(-10) and 1.7 x 10(-9) mutations per bacterium per generation in, respectively, M. kansasii and M. marinum. M. fortuitum was found to be naturally resistant to the antibiotic, whereas the nature of resistance in the other species was unclear and is discussed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4670494      PMCID: PMC444300          DOI: 10.1128/AAC.2.4.245

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Mutation and Adaptation of Phytomonas stewartii.

Authors:  R E Lincoln
Journal:  J Bacteriol       Date:  1947-12       Impact factor: 3.490

2.  Selective mechanisms in bacteria.

Authors:  K C ATWOOD; L K SCHNEIDER; F J RYAN
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1951

3.  The susceptibility of mycobacteria to rifamide and rifampicin.

Authors:  J Clark; A Wallace
Journal:  Tubercle       Date:  1967-06

4.  Action of rifamycin on RNA-polymerase from sensitive and resistant bacteria.

Authors:  W Wehrli; F Knüsel; M Staehelin
Journal:  Biochem Biophys Res Commun       Date:  1968-07-26       Impact factor: 3.575

5.  The antimycobacterial activity of rifampin.

Authors:  G L Hobby; T F Lenert
Journal:  Am Rev Respir Dis       Date:  1968-04

6.  Experimental observations on the antimycobacterial activity of rifampin.

Authors:  T F Hobby GL LENERT; J Maier-Engallena
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

7.  Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.

Authors:  L Verbist; A Gyselen
Journal:  Am Rev Respir Dis       Date:  1968-12

8.  Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction.

Authors:  B Weisblum; C Siddhikol; C J Lai; V Demohn
Journal:  J Bacteriol       Date:  1971-06       Impact factor: 3.490

9.  In vitro effect of rifampin on mycobacteria.

Authors:  V Lorian; M Finland
Journal:  Appl Microbiol       Date:  1969-02

10.  Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions.

Authors:  K D Stottmeier; G P Kubica; C L Woodley
Journal:  Appl Microbiol       Date:  1969-06
View more
  5 in total

1.  Rifampin disks in mycobacterial susceptibility testing.

Authors:  M Griffity; D Schifferle; T Midura; R M Wood
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

2.  Permeability barrier to rifampin in mycobacteria.

Authors:  J Hui; N Gordon; R Kajioka
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

3.  Case of Mycobacterium marinum infection with unusual patterns of susceptibility to commonly used antibiotics.

Authors:  Nicole Parrish; Ronald Luethke; Kim Dionne; Karen Carroll; Stefan Riedel
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

4.  Genetic and proteomic characterization of rpoB mutations and their effect on nematicidal activity in Photorhabdus luminescens LN2.

Authors:  Xuehong Qiu; Xun Yan; Mingxing Liu; Richou Han
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

Review 5.  Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.

Authors:  A Rattan; A Kalia; N Ahmad
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.